Clin2
NCT04507178Worth exploringRecruiting

Nadroparine to improve recovery after bleeding in the brain

Aneurysmal Subarachnoid HemorrhageDelayed Cerebral Ischemia

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests whether nadroparine (a blood-thinning medicine) can improve outcomes after a type of brain bleed called subarachnoid hemorrhage. It focuses on people who have had a brain aneurysm treated with a procedure soon after the bleed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have had a confirmed subarachnoid hemorrhage (brain bleeding) on a scan or spinal fluid test
  • The cause was an aneurysm, and it was confirmed on special brain blood-vessel imaging
  • Your aneurysm was treated with a coiling procedure within 72 hours of the bleed
  • You gave consent within 24 hours after the coiling procedure
  • You did not have stent-assisted coiling for the aneurysm

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07493577Not yet recruiting· Phase 1/Phase 2
Study of tirofiban to prevent complications after a bleeding brain aneurysm

This study tests a blood-thinning medicine called tirofiban to see if it helps reduce delayed brain damage after a type of stroke from a bleeding brain aneurysm. It is for people who have already had their aneurysm fixed with coiling, and the medicine is given soon after.

Durham, North Carolina
NCT06284642Recruiting· Phase 4
Drain and clot-dissolving medicine for severe aneurysm bleeding

This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.

Hefei, Anhui
NCT07642427Not yet recruiting· Phase 4
Early aspirin after aneurysm bleeding

This trial tests whether giving aspirin early after a ruptured brain aneurysm is treated can help prevent complications like vasospasm (a narrowing of brain blood vessels) and improve recovery. It is for people who have already had the aneurysm secured within 48 hours.

Ganzhou, Jiangxi
NCT07144956Not yet recruiting· Phase 3
Cilostazol plus nimodipine after brain bleed

This trial tests whether adding a drug called cilostazol to standard care (nimodipine) helps people recover better after a type of stroke caused by a bleeding brain aneurysm. It may help prevent complications like narrowing of blood vessels in the brain.

NCT06723717Recruiting· Phase 2
Daily dornase alfa after aneurysm bleed for better recovery

This trial tests whether giving dornase alfa daily for up to 14 days after a subarachnoid hemorrhage (a type of bleeding around the brain from a burst aneurysm) helps people be more independent 6 months later. It is for people whose bleeding started less than 48 hours ago and whose aneurysm has already been treated.

Grenoble, Grenoble
NCT07149922Not yet recruiting
Early blood pressure control after aneurysm treatment

This study tests whether starting blood pressure lowering treatment earlier after aneurysm repair improves recovery. If you've recently had a bleeding brain aneurysm treated, this may help reduce complications.

Beijing, Beijing Municipality

Hear when a new Aneurysmal Subarachnoid Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.